Published by Josh White on 12th February 2025
(Sharecast News) - Indivior announced a delay in the US Food and Drug Administration's (FDA) final review of proposed label changes for its 'Sublocade', or buprenorphine extended-release, injection on Wednesday.
URL: http://www.digitallook.com/dl/news/story/34875984/...